The
selective oxygenation of nonactivated carbon atoms is an ongoing
synthetic challenge, and biocatalysts, particularly hemoprotein oxygenases,
continue to be investigated for their potential, given both their
sustainable chemistry credentials and also their superior selectivity.
However, issues of stability, activity, and complex reaction requirements
often render these biocatalytic oxygenations problematic with respect
to scalable industrial processes. A continuing focus on Cytochromes
P450 (P450s), which require a reduced nicotinamide cofactor and redox
protein partners for electron transport, has now led to better catalysts
and processes with a greater understanding of process requirements
and limitations for both in vitro and whole-cell systems. However,
the discovery and development of unspecific peroxygenases (UPOs) has
also recently provided valuable complementary technology to P450-catalyzed
reactions. UPOs need only hydrogen peroxide to effect oxygenations
but are hampered by their sensitivity to peroxide and also by limited
selectivity. In this Perspective, we survey recent developments in
the engineering of proteins, cells, and processes for oxygenations
by these two groups of hemoproteins and evaluate their potential and
relative merits for scalable reactions.